OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2‐CREB‐SIRT1 axis
Li Zhang, Sheng‐Ye Yang, Feng‐Rong Qi‐Li, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 7, pp. 3898-3915
Closed Access | Times Cited: 22

Showing 22 citing articles:

SIRT1/SREBPs-mediated regulation of lipid metabolism
Shan Shen, Mingyang Shen, Lirun Kuang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107037-107037
Open Access | Times Cited: 32

Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Ziyi Chen, Wenwen Ding, Xiaoxue Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117059-117059
Closed Access | Times Cited: 26

Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 21

SIRT1: Harnessing multiple pathways to hinder NAFLD
Cheng Tian, Rongrong Huang, Ming Xiang
Pharmacological Research (2024) Vol. 203, pp. 107155-107155
Open Access | Times Cited: 9

Isoliquiritigenin from licorice flavonoids attenuates NLRP3-mediated pyroptosis by SIRT6 in vascular endothelial cells
Jianyu He, Ying Deng, Lingxuan Ren, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 115952-115952
Closed Access | Times Cited: 22

Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver
Decheng Meng, Fengxia Zhang, Wenfei Yu, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4043-4064
Open Access | Times Cited: 13

Ginsenoside Rg3 Restores Mitochondrial Cardiolipin Homeostasis via GRB2 to Prevent Parkinson's Disease
Li‐Feng‐Rong Qi, Shuai Liu, Qiuyuan Fang, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 4

Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization
Rui Zhang, Jingjing Yang, Qingqing Luo, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2217-2233
Open Access | Times Cited: 14

Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non‐alcoholic fatty liver disease
Xiangyu Hu, Chunmiao Hu, Liting Liao, et al.
Scandinavian Journal of Immunology (2024) Vol. 100, Iss. 1
Closed Access | Times Cited: 2

PPARα in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?
Claudia Theys, Dorien Lauwers, Claudina Pérez-Novo, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3041-3041
Open Access | Times Cited: 13

Liquorice root extract and isoliquiritigenin attenuate high-fat diet-induced hepatic steatosis and damage in rats by regulating AMPK
Mohammed Abdo Yahya, Ghedeir M. Alshammari, Magdi A. Osman, et al.
Archives of Physiology and Biochemistry (2022) Vol. 130, Iss. 4, pp. 385-400
Closed Access | Times Cited: 10

Anti-arrhythmia potential of honey-processed licorice in zebrafish model: Antioxidant, histopathological and tissue distribution
Wenxin Wang, Yinting Yu, Huixian Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 316, pp. 116724-116724
Closed Access | Times Cited: 5

Isoliquiritigenin attenuates non-alcoholic fatty liver disease via the amelioration of hepatic inflammation and autophagy in mice
Lina Jian, Huixing Wu, Haiyan Zeng, et al.
Journal of Functional Foods (2023) Vol. 109, pp. 105770-105770
Open Access | Times Cited: 5

Identification of Senescence-Associated Biomarkers in Diabetic Glomerulopathy Using Integrated Bioinformatics Analysis
Li Zhang, Zhaoxiang Wang, Fengyan Tang, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 1

Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities
Yanmei Liao, Fei Lv, Tianwen Quan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Traumatic acid inhibits ACSL4 associated lipid accumulation in adipocytes to attenuate high‐fat diet‐induced obesity
Jianfang Gao, Zhongxiao Zhang, Xiaohua Dong, et al.
The FASEB Journal (2023) Vol. 37, Iss. 12
Closed Access | Times Cited: 4

Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease
Paola Mogna-Peláez, Ana Romo‐Hualde, José I. Riezu‐Boj, et al.
Journal of Physiology and Biochemistry (2023)
Open Access | Times Cited: 4

Isoliquiritigenin attenuates high-fat diet-induced intestinal damage by suppressing inflammation and oxidative stress and through activating Nrf2
Mohammed Abdo Yahya, Ghedeir M. Alshammari, Magdi A. Osman, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105058-105058
Open Access | Times Cited: 6

Natural molecule isoliquiritigenin mitigates MASH and liver fibrosis in mice by promoting autophagy through the PI3K/Akt signaling pathway
Rong Liu, Yu Zhang, Min Liu, et al.
The Journal of Nutritional Biochemistry (2024), pp. 109808-109808
Closed Access

Exploring protein conformations with limited proteolysis coupled to mass spectrometry
Chloé Van Leene, Laura Van Moortel, Karolien De Bosscher, et al.
Trends in Biochemical Sciences (2024)
Open Access

Page 1

Scroll to top